BIOGEN INC. is 6.8x more valuable than Twist Bioscience Corp by market capitalization ($28.73 B vs $4.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TWST | BIIB |
|---|---|---|
| Market cap | $4.22 B | $28.73 B |
| US-listed rank | #1523 | #480 |
| Revenue (latest FY) | $376.57M | $9.89B |
| Net income (latest FY) | -$77.67M | $1.29B |
| Net margin | -20.6% | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 1,496 | 2,690 |
BIOGEN INC. is 6.8x more valuable than Twist Bioscience Corp by market capitalization ($28.73 B vs $4.22 B).
In their latest fiscal years, Twist Bioscience Corp reported $376.57M in revenue while BIOGEN INC. reported $9.89B.
Full pages: Twist Bioscience Corp and BIOGEN INC., or browse the full rankings.